Primary record
(1'R,2R,2'S,4'S,5R,7'S,8'R,9'S,12'S,13'S,16'S,18'S)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0?,?.0?,?.0??,??]icosane]-16'-ol
- 库存
- 7,651 克
- 纯度
- 98.1 %
- CAS
- 77-60-1
化合物标识与属性
- CAS
- 77-60-1
- PubChem CID
- 99516
- SMILES
- C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O)C)C)C)OC1
- Canonical SMILES
- C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C
名称与同义词
- Tigogenin
- 77-60-1
- Trigonegenin B
- (25r)-5a-spirostan-3b-ol
- TICOGENIN
- (25R)-5alpha-Spirostan-3beta-ol
- 5-epi-sarsasapogenin
- Tigogenin (Standard)
- 5-alpha-Spirostan-3-beta-ol
- A1CGZ
- TIGOGENIN [MI]
- 4SMU15RR44
- UNII-4SMU15RR44
- RefChem:1100117
- CHEBI:9595
- Spirostan-3-ol, (3b,5a,25R)-
- (5alpha,25R)-Spirostan-3beta-ol
- 22-Isoallospirostan-3|A-ol
- C27H44O3
- CHEMBL43871
- SCHEMBL330309
- DTXSID40903920
- MFCD00067287
- AC1L40Y8
- orb1301524
- CTK2H8067
- EINECS 201-041-9
- ERK5-7E17
- HY-N1403R
- GMBQZIIUCVWOCD-MFRNJXNGSA-N
- NSC 93754
- NSC-93754
- DTXCID801331880
- KST-1A5093
- Spirostan-3-ol, (3beta,5alpha,25R)-
- TIGOGENIN (REFERENCE GRADE)
- CID99516
- HY-N1403
- NSC93754
- ZINC8234227
- BRN 1293741
- ANW-58733
- AR-1A2075
- LMST01080009
- NP6051
- (3-beta,5-alpha,25R)-Spirostan-3-ol
- Spirostan-3-ol, (3ss,5a,25R)-
- (3beta,5alpha,25R)-spirostan-3-ol
- 5alpha-Spirostan-3beta-ol, (25R)-
- AKOS016002078
- ACN-047227
- C27-H44-O3
- FT42775
- J4.209I
- (25R)-3beta-Hydroxy-5alpha-spirostane
- (3-beta,5alpha,25R)-spirostan-3-ol
- (25R)-5.|A.-Spirostan-3.|A.-ol
- (25R)-5.alpha.-Spirostan-3.beta.-ol
- 5-alpha-Spirostan-3-beta-ol, (25R)-
- BS-18122
- DA-58578
- SC-18232
- SY232044
- (3beta,5alpha,17xi,25R)-spirostan-3-ol
- TC-147478
- CS-0016821
- FT-0698961
- FT-0776655
- NS00041008
- S5334
- ST24033957
- X1242
- (25R)-14beta,17beta-spirost-5-en-3beta-ol
- C08914
- Spirostan-3-ol, (3.beta.,5.alpha.,25R)-
- (2aS,2'R,4S,5'R,6aS,6bS,8aS,8bR,9S,11aS,12aS,12bR)-5',6a,8a,9-Tetramethyldocosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-ol
- (3.BETA.,5.BETA.,25R)-SPIROSTAN-3-OL
- A865190
- Q27108442
- TIGOGENIN 90%; (25R)-5-alpha-spirostan-3-beta-ol
- NSC 93754; Ticogenin; (3ss,5a,25R)-Spirostan-3-ol;
- (2R,5'R)-5'-tetramethylspiro[[?]-2,2'-tetrahydropyran]ol
- (1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-ol
- (2aS,2'R,4S,5'R,6aS,6bS,8aS,8bR,9S,11aS,12aS,12bR)-5',6a,8a,9-Tetramethyldocosahydrospiro[naphtho[2',1'
- (2aS,4S,5'R,6aS,6bS,8aS,8bR,9S,10R,11aS,12aS,12bR)-5',6a,8a,9-Tetramethyldocosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-ol
- 5001-65-0
- 5a-Spirostan-3ss-ol; (25R)-5a-Spirostan-3ss-ol; Tigogenin; (25R)-5a-Spirostan-3ss-ol;
- (1'R,2R,2'S,4'S,5R,7'S,8'R,9'S,12'S,13'S,16'S,18'S)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0?,?.0?,?.0??,??]icosane]-16'-ol
- (1'R,2R,2'S,4'S,5R,7'S,8'R,9'S,12'S,13'S,16'S,18'S)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.02,9.04,8.013,18]icosan]-16'-ol
- (1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro(5-oxapentacyclo(10.8.0.02,9.04,8.013,18)icosane-6,2'-oxane)-16-ol
- (1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-tetrahydropyran]-16-ol
- 201-041-9
- YUV